Filing Details
- Accession Number:
- 0001062993-24-009872
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-10 16:03:50
- Reporting Period:
- 2024-05-08
- Accepted Time:
- 2024-05-10 16:03:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1627223 | Chemours Co | CC | Chemicals & Allied Products (2800) | 464845564 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1994298 | Christopher Ron Charles | C/O The Chemours Company 1007 Market Street Wilmington DE 19899 | Senior Vice President, People | No | Yes | No | No |
Transaction Summary
| Number of Shares After Transactions: | 20,736 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-08 | 4,545 | $0.00 | 20,736 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-05-08 | 12,159 | $0.00 | 12,159 | $27.50 |
| Common Stock | Performance Stock Option (Right to Buy) | Acquisiton | 2024-05-08 | 12,645 | $0.00 | 12,645 | $30.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,159 | 2034-05-08 | No | 4 | A | Direct | |
| 12,645 | 2034-05-08 | No | 4 | A | Direct |
Footnotes
- Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2025.
- Includes directly owned shares, restricted stock units and dividend equivalent units.
- These options are scheduled to vest in three equal annual installments beginning on May 8, 2025.
- Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.
Billionaire Hedge Funds
